Phase3 study of docetaxel/TS-1 versus docetaxel in patients with previously treated non-small cell lung cancer - KRSG-1301

Kanto respiratory disease study group0 个研究点目标入组 260 人开始时间: 2013年8月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with severe infection is suspected or there is fever cases are complicated by severe infection 2)Cases where there is intention or possibility pregnant women, pregnancy and breast-feeding 3)Patients having double cancer of activity of simultaneity, and multiple cancer or metachronous 4)Patients with severe drug allergy 5)Cases of bleeding (hemorrhagic enteritis, ischemic colitis, necrotizing enterocolitis) and gastrointestinal ulceration 6)Cases is determined pulmonary fibrosis or interstitial pneumonia is a problem in clinical CT images from 7)Cases are complicated by lung disease emphysema of advanced, chronic bronchitis severe, such as bronchial asthma 8)Cases with pleural effusion in need of treatment of drainage, etc., and storage of pericardial effusion 9)Brain metastasis of symptomatic 10)Patients with a myocardial infarction within 3 months after onset (diabetes that is difficult to control, liver damage (cirrhosis), renal failure, angina, and arrhythmia) and serious complication 119Patients with a history of administration TS-1 or DTX before treatment 12)Case it is determined to be inappropriate other attending physician to safely performed this study

发起方

Kanto respiratory disease study group